Analyst coverage notes that JNJ’s diversified revenue base provides robust downside protection. JNJ stock forecast updates highlight the company’s ability to navigate patent expirations with new product pipelines. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. No investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance. Brokers report increased retail investor interest in JNJ after its recent market dip, viewing current levels as an attractive entry point in line with forecast upside of 8‑10% over 12 months.